Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,282.40
(
0.00%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.86
(
1.60%
)
Bitcoin
68,005.96
(
0.25%
)
News Focus
News Focus

Replies to post #163878 on Biotech Values

Replies to #163878 on Biotech Values
icon url

jq1234

07/11/13 7:53 PM

#163880 RE: mcbio #163878

I think that's your hope. If GILD depends on sofosbuvir/ribavirin combo with longer treatment duration for GT1, they are doomed! This is a phase 3b study, you are reading too much into it beyond the current pending NDA.